scholarly article | Q13442814 |
P356 | DOI | 10.1159/000209289 |
P698 | PubMed publication ID | 19293564 |
P50 | author | Sebastian Schneeweiss | Q60162120 |
John D Seeger | Q91589185 | ||
P2093 | author name string | Raymond G Schlienger | |
Shao Zhu | |||
Mike Doherty | |||
Donnie Funch | |||
Carlos Fernandez-Vidaurre | |||
P433 | issue | 1 | |
P304 | page(s) | 7-21 | |
P577 | publication date | 2009-03-17 | |
P1433 | published in | Dermatology | Q5262700 |
P1476 | title | Topical treatments with pimecrolimus, tacrolimus and medium- to high-potency corticosteroids, and risk of lymphoma | |
P478 | volume | 219 |
Q51099897 | 2% Crisaborole topical ointment for the treatment of mild-to-moderate atopic dermatitis. |
Q52646026 | A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation - JOELLE study). |
Q35733343 | Association Between Malignancy and Topical Use of Pimecrolimus |
Q39224205 | CSACI position statement: safety of topical calcineurin inhibitors in the management of atopic dermatitis in children and adults. |
Q38807878 | Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016. |
Q36573102 | Disease-modifying antirheumatic drug use and the risk of incident hyperlipidemia in patients with early rheumatoid arthritis: a retrospective cohort study |
Q37861867 | Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors. |
Q30465036 | Geographic and climatic factors associated with exfoliation syndrome. |
Q37865056 | Optimizing the treatment of atopic dermatitis in children: a review of the benefit/risk ratio of methylprednisolone aceponate |
Q38266892 | Photocarcinogenicity of selected topically applied dermatological drugs: calcineurin inhibitors, corticosteroids, and vitamin D analogs |
Q28086973 | Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants |
Q34167722 | Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study |
Q36042131 | Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis |
Q89175645 | Tacrolimus ointment for the treatment of adult and pediatric atopic dermatitis: Review on safety and benefits |
Q36892767 | Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice |
Q24597375 | Topical calcineurin inhibitors for atopic dermatitis: review and treatment recommendations |
Q39859545 | Topical calcineurin inhibitors in eczema and cancer association: A cohort study |
Q40122276 | Topical calcineurin inhibitors in systemic lupus erythematosus |
Q37624689 | Topical pimecrolimus: a review of its use in the management of pediatric atopic dermatitis |
Q24186624 | Topical tacrolimus for atopic dermatitis |
Q38419338 | Treatment of Eczema: Corticosteroids and Beyond |
Q42708359 | Treatment patterns and costs of care for patients with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin in the United States: A retrospective cohort study |
Search more.